Botanix Pharmaceuticals (ASX: BOT) executive chairman Vince Ippolito joins Small Caps to discuss the company's acquisition of novel...

Botanix Pharmaceuticals (ASX: BOT) acquires Sofpironium Bromide gel to treat excessive underarm sweating (w/ Vince Ippolito)

<p>Small Caps is Australia's #1 site for investor news &amp; information on ASX listed small cap companies. The podcast keeps investors informed by showcasing interviews with directors of ASX listed small cap companies and financial market analysts. For more information visit: https://smallcaps.com.au/.</p>

Business

News

Investing

Business News

Small Caps is Australia's #1 site for investor news & information on ASX listed small cap companies. The podcast keeps investors informed by showcasing interviews with directors of ASX listed small cap companies and financial market analysts. For more information visit: https://smallcaps.com.au/.

Share Botanix Pharmaceuticals (ASX: BOT) acquires Sofpironium Bromide gel to treat excessive underarm sweating (w/ Vince Ippolito)

Sign up to save your podcasts

Botanix Pharmaceuticals (ASX: BOT) acquires Sofpironium Bromide gel to treat excessive underarm sweating (w/ Vince Ippolito)

Botanix Pharmaceuticals (ASX: BOT) acquires Sofpironium Bromide gel to treat excessive underarm sweating (w/ Vince Ippolito)

More shows like Small Caps

CommSec Market Update

Motley Fool Money

NAB Morning Call

The Money Puzzle

Equity Mates Investing Podcast

The Rules of Investing

Your Wealth

Australian Investors Podcast

Australian Finance Podcast

Money of Mine

Get Started Investing

Buy Hold Sell, by Livewire Markets

The Call from ausbiz

The Money Café with Alan Kohler

Chanticleer